Adherence to Safe Handling Guidelines by Health Care Workers Who Administer Antineoplastic Drugs

REFERENCES

• National Institute for Occupational Safety and Health (NIOSH): “NIOSH List of Antineoplastic and Other Hazardous Drugs in Health Care Settings.” Available at http://www.cdc.gov/niosh/docs/2010-167 (accessed October 21, 2013).
   Google Scholar
• National Institute for Occupational Safety and Health (NIOSH): “Workplace Solutions: Personal Protective Equipment for Health Care Workers Who Work with Hazardous Drugs.” Available at http://www.cdc.gov/niosh/docs/wp-solutions/2009-106/ (accessed October 21, 2013).
   Google Scholar
• Connor, T.H., andM.A. McDiarmid: Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J. Clin. 56:354–365 (2006).
   PubMed Web of Science ®Google Scholar
• Rosner, F.: Acute leukemia as a delayed consequence of cancer chemotherapy. Cancer 37:1033–1036 (1976).
   PubMed Web of Science ®Google Scholar
• Kyle, R.A.:Second Malignancies Associated with Chemotherapy. In Toxicity of Chemotherapy, M.C. Perry and J.W. Yarbro (eds.). Orlando, Fla.: Grune and Stratton, 1984. pp. 479–506.
   Google Scholar
• Wall, R.L., andK.P. Clausen: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N. Engl. J. Med. 293:271–273 (1975).
   PubMed Web of Science ®Google Scholar
• Valanis, B.G., W.M. Vollmer, K.T. Labuhn, andA.G. Glass: Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nurs. 16:288–295 (1993).
   PubMed Web of Science ®Google Scholar
• Valanis, B.G., W.M. Vollmer, K.T. Labuhn, andA.G. Glass: Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am. J. Hosp. Pharm. 50:455–462 (1993).
   PubMedGoogle Scholar
• Lawson, C.C., C.M. Rocheleau, E.A. Whelan, et al.: Occupational exposures among nurses and risk of spontaneous abortions. Am. J. Obstet. Gynecol. 206: 327.e1–8 (2012).
   Google Scholar
• Skov, T., B. Maarup, J. Olsen, M. Rorth, H. Winthereik, andE. Lynge: Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br. J. Ind. Med. 49:855–861 (1992).
   PubMedGoogle Scholar
• Suspiro, A., and J. Prista: Biomarkers of occupational exposure do anticancer agents: A mini-review. Toxicol. Lett. 207:42–52 (2011).
   PubMed Web of Science ®Google Scholar
• McDiarmid, M.A., M.S. Oliver, T.S. Roth, B. Rogers, andC. Escalante: Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J. Occup. Environ. Med. 52:1028–1034 (2010).
   PubMed Web of Science ®Google Scholar
• American Society of Health-System Pharmacists: Technical Assistance Bulletin on Handling Cytotoxic Drugs in Hospitals. American Society of Hospital Pharmacists. Am. J. Hosp. Pharm. 42:131–137 (1985).
   Google Scholar
• Oncology Nursing Society: Cancer Chemotherapy Guidelines, Modules I–V. Pittsburgh, Pa.: Oncology Nursing Society, 1988.
   Google Scholar
• National Institute for Occupational Safety and Health (NIOSH): “NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings.” Available at http://www.cdc.gov/niosh/docs/2004-165/ (accessed October 21, 2013).
   Google Scholar
• Occupational Safety and Health Administration (OSHA): “Controlling Occupational Exposure to Hazardous Drugs.” In OSHA Technical Manual, TED 1-0.15A, section VI, chapter 2, 1999. . Available at http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html (accessed October 21, 2013).
   Google Scholar
• Manuele, F.A.: Risk assessment and hierarchies of control: Their growing importance to the SH&E profession. Prof. Saf. 50:33–39 (2005).
   Google Scholar
• Stajicj, G.V., C.W. Barnett, S.V. Turner, andC.A. Henderson: Protective measures used by oncology office nurses handling parenteral antineoplastic agents. Oncol. Nurs. Forum 13:47–49 (1986).
   PubMedGoogle Scholar
• Valanis, B., and L. Shortridge: Self protective practices of nurses handling antineoplastic drugs. Oncol. Nurs. Forum 14:23–27 (1987).
   PubMedGoogle Scholar
• Valanis, B., V. McNeil, andK. Driscoll: Staff members’ compliance with their facility's antineoplastic drug handling policy. Oncol. Nurs. Forum 19:571–576 (1991).
   Google Scholar
• Valanis, B., W.M. Vollmer, K. Labuhn, A. Glass, andC. Corelle: Antineoplastic drug handling protection after OSHA guidelines. Comparison by profession, handling activity, and work site. J. Occup. Med. 34:149–155 (1992).
   PubMedGoogle Scholar
• Mahon, S.M., D.S. Casperson, S. Yackzan, et al.: Safe handling practices of cytotoxic drugs: The results of a chapter survey. Oncol. Nurs. Forum 21:1157–1165 (1994).
   PubMedGoogle Scholar
• Nieweg, R.M., M. de Boer, R.C. Dubbleman, et al.: Safe handling of antineoplastic drugs. Results of a survey. Cancer Nurs. 17(6):501–511 (1994).
   PubMed Web of Science ®Google Scholar
• Martin, S., and E. Larson: Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncol. Nurs. Forum 30:575–581 (2003).
   PubMedGoogle Scholar
• Fuller, T.P., E.I. Bain, K. Sperrazza, andL.F. Mazzuckelli: A survey of the status of hazardous drug awareness and control in a sample Massachusetts nursing population. J. Occup. Environ. Hyg. 4(11):D113–D119 (2007).
   PubMed Web of Science ®Google Scholar
• Stover, D., and C. Achutan: Occupational exposures to antineoplastic drugs in an oncology-hematology department. J. Occup. Environ. Hyg. 8:D1–D6 (2011).
   PubMed Web of Science ®Google Scholar
• Polovich, M., and S. Martin: Nurses’ use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncol. Nurs. Forum 38:718–726 (2011).
   PubMed Web of Science ®Google Scholar
• Polovich, M., and P.C. Clark: Factors influencing oncology nurses’ use of hazardous drug safe-handling precautions. Oncol. Nurs. Forum 39:E299–E309 (2012).
   PubMedGoogle Scholar
• Friese, C.R., L. Himes-Ferris, M.N. Frasier, M.C. McCullagh, andJ.J. Griggs: Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Qual. Saf. 21:753–759 (2012).
   PubMed Web of Science ®Google Scholar
• Steege, A.L., J.M. Boiano, andM.H. Sweeney: NIOSH Health and Safety Practices Survey of Health Care Workers: Training and awareness of employer safety procedures. Am. J. Ind. Med. 57:640–652 (2014).
   Google Scholar
• American Society of Hospital Pharmacists (ASHP): ASHP Guidelines on Handling Hazardous Drugs. Am. J. Health Syst. Pharm. 63:1172–1193 (2006).
   Google Scholar
• Polovich, M., J.M. White, andM. Olsen: Chemotherapy and Biotherapy Guidelines and Recommendations for Practice, 3rd ed. Pittsburgh, Pa.: Oncology Nursing Society (2009).
   Google Scholar
• Centers for Disease Control and Prevention (CDC): “Distinguishing Public Health Research and Public Health Nonresearch.” Available at http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf (accessed December 18, 2013).
   Google Scholar